Enjoy complimentary customisation on priority with our Enterprise License!
The non-alcoholic steatohepatitis (NASH) market size is forecast to increase by USD 31.46 billion at a CAGR of 58.37% between 2023 and 2028. The market is experiencing significant growth due to several key drivers. The rising prevalence of obesity and metabolic syndrome, which are major risk factors for NASH, is a significant market growth factor. Additionally, the lack of approved therapies for NASH presents an opportunity for new treatments and interventions. Another trend in the market is increasing patient engagement and education, as people become more aware of the symptoms and potential complications of NASH. However, challenges remain, including the need for effective lifestyle modifications to manage the condition and the high rate of inflammation and liver damage in patients. Furthermore, the high cost of liver transplants and the potential for genetic factors to contribute to the development of NASH add complexity to the market.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Distribution Channel
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.